COMPOUND AND USE IN TREATMENT
Application 577/KOL/2004 published 2006-01-20, filed 2004-09-22
The use of 1 -alpha-fluoro-25-hydroxy-16,23E-diene-26,27-bishomo-20-epi-cholecalciferol, or a pharmaceutically acceptable salt or ester thereof for the manufacture of a medicament for the prevention and/or treatment of benign prostatic hyperplasia (BPH) and associated symptoms. (FIG. Nil)
Applicant
BIOXELL SPA.,
VIA OLGETTINA 58, I-20132 MILAN, ITALY.
Inventor
International Info
Classification: A61K 31/59, C07C 401/00
Priority Information
0322395.5 UK 2003-09-24
0325598.1 UK 2003-11-03
0416876.1 UK 2004-07-29